BNET Industries
Market Cap:$12.3B
Last Fiscal Year Sales:$3.7B
- Public
- US
Dow Jones Description
St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. Headquartered in St. Paul, Minn., St. Jude Medical employs approximately 14,000 people worldwide and has four major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. The St. Jude Medical product portfolio includes implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, pacemakers, electrophysiology catheters, mapping and visualization systems, vascular closure devices, heart valve replacement and repair products, and neurostimulation devices.
Number of Employees 14,000
Peer Companies
NAICS Code Electromedical and Electrotherapeutic Apparatus Manufacturing: 334510
Recent Events
-
St. Jude's Stock Is No Hopeless Cause
-
St. Jude Medical Gets FDA Nod For Penta Surgical Lead To Manage Chronic Pain -...
-
SJM Releases New Neurostimulator Programming Software
-
Morgan Joseph Initiates Coverage on St. Jude Medical STJ with a Buy; High-Quality Name in...
-
UPDATE: St. Jude Leaves Trade Group AdvaMed In Tax Dispute
-
Zacks Analyst Blog Highlights: Morgan Stanley, Goldman Sachs, St.
-
Was the St. Jude sell-off overdone?
-
Canaccord Adams Downgrades St. Jude Medical Inc. STJ to Hold
-
David Moenning's Daily State of the Markets: Voting With Their Feet
-
Edwards Lifesciences Q3 Profit More Than Doubles; Updates FY09 Outlook
-
Uncertainty in face of reform
-
St. Jude Medical Announces Australian Launch of Devices that Diagnose and Treat Abnormal Heart Rhythms
-
Zacks Analyst Blog Highlights: Fannie Mae, Freddie Mac, St. Jude Medical, Medtronic and Boston...
-
Micell gets investment from St. Jude Medical
-
$15 million infusion for Micell
-
St. Jude Medical to Showcase Complete Cardiovascular Access, Intervention and Hemostasis...
-
St. Jude Medical Announces European Launch of New Version of
-
St. Jude Medical Announces European Launch of New Version of Remote Patient Care Network
News & Analysis
Filter by
patient and st. jude medical inc. - All News and Analysis
St. Jude Medical Completes Milestone to Standardize Patient Medical Records
- 2007-02-27
St. Jude Medical is first cardiac rhythm management device maker to participate in test of communications standards initiative to improve healthcare information sharing
St. Jude Medical Announces FDA Clearance of Spinal Cord Stimulation Leads for Patients with Low Back Pain
- 2007-02-15
Tripole 16C helps physicians customize care with 16 independent electrodes
St. Jude Medical Announces FDA Approval and Launch of QuickOpt™ Timing Cycle Optimization for Heart Failure and ICD Patients; Innovative Feature Addresses 'Non-Optimization' of Device Patients
- 2006-08-22
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration FDA approval and launch of QuickOptTM Timing Cycle Optimization. This new programmer feature is designed to help physicians improve patient outcomes for people with cardiac resynchronization therapy defibrillator (CRT-D) devices and traditional implantable cardioverter...
St. Jude Medical Announces FDA Approval of Atlas II ICD and Atlas II Heart Failure Devices; Powerful, High-Energy Devices Are Designed to Help Patients Whose Hearts Are Especially Difficult to Defibrillate
- 2006-07-18
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration FDA approval of new, powerful devices for treating patients with potentially lethal heart arrhythmias and heart failure.
IBM collaborates with St. Jude Medical on new state-of-the-art cardiac patient care system
BNET
- 2006-05-31
Breakthrough technology designed to help physicians more efficiently monitor, program ICDs & pacemakers.
St. Jude Medical Announces FDA Approval and U.S. Market Launch of the Merlin Patient Care System; New Programmer Brings 21st Century Advances to Patient Follow-Ups
- 2006-04-17
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration FDA approval and market launch of its MerlinTM Patient Care System, a universal programmer for implantable cardioverter defibrillators ICDs and pacemakers. The system is designed to help physicians more efficiently conduct tests, analyze therapeutic...
First Patient Enrolled in St. Jude Medical's Migraine Headache Study; Clinical Trial to Explore Link between Common Heart Defect and Migraine Headaches
- 2006-03-02
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced the enrollment of the first patient in its ESCAPE (Effect of Septal Closure of Atrial PFO on Events of Migraine with PremereTM) migraine trial.
St. Jude Medical Announces Publication of OPTIC Clinical Study Results in JAMA; Study May Hold the Key to Reducing Shocks in ICD Patients
- 2006-01-10
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced publication of the OPTIC Optimal Pharmacological Therapy in Implantable Cardioverter Defibrillator Patients clinical study results in the January 11 edition of The Journal of the American Medical Association JAMA. The study, sponsored by St. Jude Medical, shows that patients...
First Patients Enrolled in St. Jude Medical's Study Looking at AF Suppression Pacing in Heart Failure Patients
- 2005-11-17
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced that patient enrollment has begun in the Atrial Fibrillation Suppression Pacing in Cardiac Resynchronization Therapy Devices (CRT-D) clinical study. The study evaluates the Company's proprietary AF SuppressionTM algorithm, clinically proven to suppress episodes of atrial fibrillation AF, and how...
St. Jude Medical Announces FDA Approval of New Housecall Plus™ System Software Designed to Advance Remote Patient Monitoring
- 2005-07-07
ST. PAUL, Minn. -- In an effort to provide important new communications benefits to medical professionals who remotely monitor implantable cardioverter defibrillator ICD patients, St. Jude Medical, Inc. (NYSE:STJ) announced today it has received U.S. Food and Drug Administration FDA approval of its version 2.1 software upgrade for the Housecall...
- 1
- 2
Industry Transcripts by Seeking Alpha
-
Hansen Medical, Inc. Q3 2009 Earnings Call Transcript
on Dec 18, 2009about HNSN
-
Synergetics USA, Inc. F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 16, 2009about SURG
-
Cantel Medical Corp. F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 09, 2009about CMN
-
The Cooper Companies, Inc. F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 08, 2009about COO
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
Glass Door
St. Jude Medical
IndustryTop Rated
Presented by American Express